Frontlight ResearchEarly access
Active, not recruitingNo phase
The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
Key facts
- Who runs it
- Medtronic Heart Valves
- Where
- Columbus, Houston, Los Angeles, New Haven, Palo Alto, Philadelphia, Rochester, Salt Lake City, and Seattle, United StatesSee the 9 sitesAlso in 2 other countries, 3 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 86 people enrolled
- Started
- Jan 2017
- Expected to end
- Feb 2031
- Type of study
- Interventional
- Treatments tested
- Harmony TPV System
- Record updated
- 19 September 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Subject has severe pulmonary regurgitation as assessed via echocardiography or CMR determined PR fraction >/= 30%
- Subject has clinical indication for surgical placement of an RV-PA conduit or bioprosthetic pulmonary valve
- Subject is willing to consent to participate
Who cannot take part
- Patients with right ventricular outflow tract obstruction (RVOTO) lesions surgically treated with an RV-to-PA conduit implant
- RVOT anatomy or morphology that is unfavorable for device anchoring
- Positive pregnancy test
- Life expectancy of less than 1 year
Where in United States
Also in 2 other countries, 3 sites
- Nationwide Children's HospitalColumbus, United States
- Texas Children's HospitalHouston, United States
- Ronald Regan UCLA Medical CenterLos Angeles, United States
- Yale UniversityNew Haven, United States
- Stanford University Medical CenterPalo Alto, United States
- The Children's Hospital Of PhiladelphiaPhiladelphia, United States
- Mayo ClinicRochester, United States
- Primary Children's HospitalSalt Lake City, United States
- Seattle Children's HospitalSeattle, United States
About the trial
What the trial wants to find out
The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system. The Pivotal/CAS phases of the study have transitioned into a post-approval study to confirm the long-term functionality of transcatheter implantation of the Medtronic Harmony TPV.
The group in the trial
- Harmony TPV SystemOther group
Intervention Device: Harmony Transcatheter Pulmonary Valves and Delivery Systems
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients.Circulation. Cardiovascular interventions, 2025
- Record updated
- 19 September 2025